41438-18-0

Basic information

• Product Name: 4-Hydroxy-2-methylbenzaldehyde
• Synonyms: 4-HYDROXY-2-METHYLBENZALDEHYDE;4-Hydroxy-2-methylbenzenecarbaldehyde;4-Hydroxy-o-tolualdehyde. m-Cresol-4-aldehyde. 4,2;Benzaldehyde, 4-hydroxy-2-methyl-
• CAS NO: 41438-18-0
• Molecular Formula: C₈H₈O₂
• Molecular Weight: 136.15
• Product Categories: Aromatic Aldehydes & Derivatives (substituted);Benzaldehyde
• Mol File: 41438-18-0.mol
• Article Data: 17

Chemical Properties

• Melting Point: 104-107°C
• Boiling Point: 265.5 °C at 760 mmHg
• Flash Point: 110.4 °C
• Appearance: /
• Density: 1.175 g/cm³
• Vapor Pressure: 0.00556mmHg at 25°C
• Refractive Index: 1.601
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 7.89±0.18(Predicted)
• CAS DataBase Reference: 4-Hydroxy-2-methylbenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Hydroxy-2-methylbenzaldehyde(41438-18-0)
• EPA Substance Registry System: 4-Hydroxy-2-methylbenzaldehyde(41438-18-0)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 36/37/38-52-41-37/38
• Safety Statements: 26-36/37/39-39
• Hazardous Substances Data: 41438-18-0(Hazardous Substances Data)

Usage

General Description

4-Hydroxy-2-methylbenzaldehyde is a chemical compound that falls under the category of aromatic aldehydes. This organic compound is represented by the formula C8H8O2. It is typically used in a variety of industrial applications, including in the production of chemicals and pharmaceuticals. In its solid state, it appears as white to off-white crystals. Safety measures should be observed when handling this chemical as it could cause eye and skin irritation, respiratory irritation, and serious eye damage.

InChI:InChI=1/C8H8O2/c1-6-4-8(10)3-2-7(6)5-9/h2-5,10H,1H3

Upstream product

• 557-21-1 dicyanozinc 
• 108-39-4 3-methyl-phenol 
• 661481-12-5 2-methyl-4-(methoxymethoxy)benzaldehyde 
• 14143-26-1 4-hydroxy-2-methylbenzonitrile 
• 4885-02-3 Dichloromethyl methyl ether 
• 206122-92-1 4-allyloxy-2-methyl-benzaldehyde 
• 100-84-5 1-methoxy-3-methyl-benzene 
• 27060-75-9 4-bromo-3-methylanisole 
• 67-66-3 chloroform 
• 7647-01-0 hydrogenchloride 
• 7446-70-0 aluminium trichloride 
• 71-43-2 benzene 
• 80193-36-8 4-[1,3]Dithiolan-2-yl-3-methyl-phenol 
• 4832-52-4 tris(phenylthio)methane 

Downstream Products

• 120802-54-2 4-tosyloxy-2-methylbenzaldehyde 
• 102479-64-1 nicotinic acid-(4-benzyloxy-2-methyl-benzylidenehydrazide) 
• 102479-63-0 isonicotinic acid-(4-benzyloxy-2-methyl-benzylidenehydrazide) 
• 1105536-08-0 C₁₂H₁₇NO₂ 
• 68097-79-0 3-methyl-4-piperidin-1-ylmethyl-phenol 
• 1426665-71-5 4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-3-methylphenol 
• 1426666-59-2 methyl (3-(4-hydroxy-2-methylphenyl)-3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-10-yl)carbamate 
• 1264751-16-7 (5Z)-5-[(4-{[2,4-bis(trifluoromethyl)benzyl]oxy}-2-methylphenyl)methylidene]-4-(methylamino)-1,3-thiazol-2(5H)-one 
• 1264754-18-8 (5Z)-5-[(4-{[2,4-bis(trifluoromethyl)benzyl]oxy}-2-methylphenyl)methylidene]-4-thioxo-1,3-thiazolidin-2-one 
• 1264753-77-6 (5Z)-5-[(4-{[2,4-bis(trifluoromethyl)benzyl]oxy}-2-methylphenyl)methylidene]-1,3-thiazolidine-2,4-dione 
• 1264753-62-9 4-{[2,4-bis(trifluoromethyl)benzyl]oxy}-2-methylbenzaldehyde 
• 1354792-67-8 2-methyl-4-(1-(5-phenyl-1,3,4-oxadiazole-2-carbonyl)azetidin-3-yloxy)benzaldehyde 
• 1354792-78-1 tert-Butyl 3-(4-((4-(hydroxymethyl)-4-methylpiperidin-1-yl)methyl)-3-methylphenoxy)azetidine-1-carboxylate 
• 1354792-77-0 tert-Butyl 3-(4-formyl-3-methylphenoxy)azetidine-1-carboxylate 

Relevant articles and documents

Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist

The long chain free fatty acid receptor 4 (FFA4/GPR120) has recently been recognized as lipid sensor playing important roles in nutrient sensing and inflammation and thus holds potential as a therapeutic target for type 2 diabetes and metabolic syndrome. To explore the effects of stimulating this receptor in animal models of metabolic disease, we initiated work to identify agonists with appropriate pharmacokinetic properties to support progression into in vivo studies. Extensive SAR studies of a series of phenylpropanoic acids led to the identification of compound 29, a FFA4 agonist which lowers plasma glucose in two preclinical models of type 2 diabetes.

Formylation of electron-rich aromatic rings mediated by dichloromethyl methyl ether and TiCl4: Scope and limitations

Here the aromatic formylation mediated by TiCl4 and dichloromethyl methyl ether previously described by our group has been explored for a wide range of aromatic rings, including phenols, methoxy- and methylbenzenes, as an excellent way to produce aromatic aldehydes. Here we determine that the regioselectivity of this process is highly promoted by the coordination between the atoms present in the aromatic moiety and those in the metal core.

PYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, MEDICINAL USE THEREOF, AND INTERMEDIATE FOR PRODUCTION THEREOF

The present invention provides pyrazole derivatives represented by the general formula: wherein R1 represents H, an optionally substituted C1-6 alkyl group etc.; one of Q and T represents a group represented by the general formula: or a group represented by the general formula: while the other represents an optionally substituted C1-6 alkyl group etc.; R2 represents H, a halogen atom, OH, an optionally substituted C1-6 alkyl group etc.; X represents a single bond, O or S; Y represents a single bond, a C1-6 alkylene group etc. ; Z represents CO or SO2; R4 and R5 represent H, an optionally substituted C1-6 alkyl group etc.; and R3, R6 and R7 represent H, a halogen atom etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT1 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.